REG - Essentra plc - Transaction in Own Shares

EssentraAnnouncement

29/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230929:nRSc0782Oa&default-theme=true

RNS Number : 0782O  Essentra plc  28 September 2023

28 September 2023

ESSENTRA PLC

Transaction in Own Shares

 

The following amendment has been made to the 'Transaction in Own Shares'
announcement released on 22 September 2023 at 07:00 under RNS No 2955N.

The aggregate number of Ordinary 25p shares purchased was reported as 1,
whereas 65,000 shares were purchased.

Following the settlement of the above purchases and cancellation, on 21
September 2023, Essentra had 291,156,946 Ordinary Shares of 25 pence each in
issue (excluding 5,039,265 Ordinary Shares of 25 pence each held in treasury),
and not 291,221,945 as previously reported.

All other details remain unchanged.

The full amended text is shown below.

Essentra plc ("Essentra", or the "Company") announces that on 21 September
2023 it purchased the following number of its ordinary shares of 25 pence each
in the Company ("Ordinary Shares") from Peel Hunt LLP as part of the buyback
programme announced on 29 March 2023 (the "Buyback Programme").

 ESSENTRA ORD 25P
 Date of purchase:                                    21/09/2023
 Aggregate number of Ordinary 25p Shares purchased:   65,000
 Lowest price paid per share (GBp):                   151.0000
 Highest price paid per share (GBp):                  151.0000
 Volume weighted average price paid per share (GBp):  151.0000
 Broker                                               PEEL HUNT

 

Essentra intends to cancel the purchased Ordinary Shares.

Following the settlement of the above purchases and cancellation, Essentra has
291,156,946 Ordinary Shares of 25 pence each in issue (excluding 5,039,265
Ordinary Shares of 25 pence each held in treasury).

 

The figure 291,156,946 represents the total number of voting rights in
Essentra and can be used by shareholders as the denominator for the
calculations by which they can determine if they are required to notify their
interest in, or change to their interest in, the Company under the Financial
Conduct Authority's Disclosure and Transparency Rules.

 Trading Venue                 Volume-weighted average price paid per share (Gbp)  Aggregated number of shares purchased
 BATS (BATE)                   -                                                   -
 BATS (BATP)                   -                                                   -
 Chi-X (CHIX)                  -                                                   -
 Chi-X (CHID)                  -                                                   -
 London Stock Exchange (XLON)  151.0000                                            65,000
 Total                         151.0000                                            65,000

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such
Regulation has become part of domestic law by virtue of and for the purposes
of the European Union (Withdrawal) Act 2018 (as amended by the European Union
(Withdrawal Agreement) Act 2020) and as such Regulation has been amended in
such form by any regulations made under that Act), the schedule below contains
detailed and aggregated information of the individual trades made by Peel Hunt
LLP as part of the Buyback Programme.

This announcement is made in accordance with the requirements of Listing Rule
12.4.6.

 

For further enquiries, please contact:

Essentra plc

Amina Olatunji, Assistant Company Secretary

Tel: +44 (0)1908 359100

Schedule of Purchases - Individual Transactions

 Number of shares purchased  Transaction price (Gbp)  Market / Sytematic Internaliser  Time of transaction              Trade ID
 65000                       151                      XLON                             20230921 10:15:13.817568 +0100s  00153418634TRLO0

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSZZGZLRRLGFZM